CD 45 antibody for conditioning in allogeneic − astatine-211-emitter α Durable donor engraftment after radioimmunotherapy using

http://bloodjournal.hematologylibrary.org/content/119/5/1130.full.html Updated information and services can be found at: (1823 articles) Transplantation • (1541 articles) Free Research Articles • (3626 articles) Clinical Trials and Observations • Articles on similar topics can be found in the following Blood collections http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprints Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtml Information about subscriptions and ASH membership may be found online at:

[1]  G. Glatting,et al.  Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases. , 2011, Blood.

[2]  H. Kahu,et al.  RBE of α-particles from 211At for complex DNA damage and cell survival in relation to cell cycle position , 2011, International journal of radiation biology.

[3]  E. Ron,et al.  Non-malignant Thyroid Diseases after a Wide Range of Radiation Exposures , 2010, Radiation research.

[4]  R. Storb,et al.  Pilot Study of a 213Bismuth-Labeled Anti-CD45 mAb as a Novel Nonmyeloablative Conditioning for DLA-Haploidentical Littermate Hematopoietic Transplantation , 2010, Transplantation.

[5]  G. Kanel,et al.  Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury. , 2009, Gastroenterology.

[6]  R. Storb,et al.  Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211. , 2009, Cancer research.

[7]  Y. Sugimoto,et al.  Hematopoietic origin of hepatic stellate cells in the adult liver. , 2008, Blood.

[8]  M. Brechbiel,et al.  Selective T-cell ablation with bismuth-213–labeled anti-TCRαβ as nonmyeloablative conditioning for allogeneic canine marrow transplantation , 2003 .

[9]  M. Brechbiel,et al.  Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts. , 2002, Blood.

[10]  H. Döhner,et al.  Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study. , 2001, Blood.

[11]  Eva Forssell-Aronsson,et al.  Similarities and differences between free 211At and 125I- transport in porcine thyroid epithelial cells cultured in bicameral chambers. , 2001, Nuclear medicine and biology.

[12]  F. Azzaroli,et al.  Immunology of the healthy liver: old questions and new insights. , 2001, Gastroenterology.

[13]  J. Roeske,et al.  Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cells. , 1999, Radiation research.

[14]  Lake.  THE USE OF AN ANTI-TCRab MONOCLONAL ANTIBODY TO CONTROL HOST-VERSUS-GRAFT REACTIONS IN CANINE MARROW ALLOGRAFT RECIPIENTS CONDITIONED WITH LOW DOSE TOTAL BODY IRRADIATION 1 , 1999 .

[15]  R. Storb,et al.  Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model. , 1998, Blood.

[16]  H. Deeg,et al.  Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. , 1997, Blood.

[17]  R. Vessella,et al.  Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin. , 1996, Bioconjugate chemistry.

[18]  E. Ostrander,et al.  Histocompatibility testing of dog families with highly polymorphic microsatellite markers. , 1996, Transplantation.

[19]  K. Magnusson,et al.  Liver cell uptake and degradation of soluble immunoglobulin G immune complexes in vivo and in vitro in rats , 1996, Hepatology.

[20]  E. Scanziani,et al.  Canine Lymphoma: Immunocytochemical Analysis of Fine-needle Aspiration Biopsy , 1996, Veterinary pathology.

[21]  T. Wheldon,et al.  Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  M. Anscher,et al.  Hepatic toxicity resulting from cancer treatment. , 1995, International journal of radiation oncology, biology, physics.

[23]  E. Bryant,et al.  USE OF (CA)n POLYMORPHISMS TO DETERMINE THE ORIGIN OF BLOOD CELLS AFTER ALLOGENEIC CANINE MARROW GRAFTING , 1994, Transplantation.

[24]  C. Jacobsen,et al.  Reactivities of 20 anti-human monoclonal antibodies with leucocytes from ten different animal species. , 1993, Veterinary immunology and immunopathology.

[25]  R. Vessella,et al.  Preparation and evaluation of para-[211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab')2. In vivo distribution comparison with para-[125I]iodobenzoyl labeled A6H F(ab')2. , 1993, Nuclear medicine and biology.

[26]  H. Deeg,et al.  Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model. , 1993, International journal of radiation oncology, biology, physics.

[27]  I. Bernstein,et al.  THE USE OF RADIOLABELED ANTI‐CD33 ANTIBODY TO AUGMENT MARROW IRRADIATION PRIOR TO MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA , 1992, Transplantation.

[28]  D. Danilenko,et al.  Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. , 1992, Tissue antigens.

[29]  I. Bernstein,et al.  Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody. , 1992, Cancer research.

[30]  I. Bernstein,et al.  Biochemical characterization of a unique canine myeloid antigen. , 1991, Leukemia.

[31]  W. Inkret,et al.  Radiobiology of alpha particles. III. Cell inactivation by alpha-particle traversals of the cell nucleus. , 1991, Radiation research.

[32]  J. Eary,et al.  Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque. , 1991, Blood.

[33]  R. Storb,et al.  An antibody that facilitates hematopoietic engraftment recognizes CD44. , 1990, Blood.

[34]  R. Storb,et al.  Canine models of bone marrow transplantation. , 1990, Laboratory animal science.

[35]  J. McKenzie,et al.  Characterization of interstitial dendritic cells in human liver. , 1988, Transplantation.

[36]  C. Coleman,et al.  Radioimmunotherapy with alpha-particle-emitting immunoconjugates. , 1988, Science.

[37]  H. Deeg,et al.  Morphologic and phenotypic analysis of canine natural killer cells: evidence for T-cell lineage. , 1985, Cellular immunology.

[38]  I. Bernstein,et al.  Influence of antibody isotype on passive serotherapy of lymphoma. , 1985, Journal of immunology.

[39]  H. Deeg,et al.  The canine major histocompatibility complex. Population study of DLA-D alleles using a panel of homozygous typing cells. , 2008, Tissue antigens.

[40]  M. Kadin,et al.  Immunologic markers in the differential diagnosis of small round cell tumors from lymphocytic lymphoma and leukemia. , 1983, American journal of clinical pathology.

[41]  M. Omary,et al.  Human homologue of murine T200 glycoprotein , 1980, The Journal of experimental medicine.

[42]  J. G. Hamilton,et al.  Effects of Thyroxine and KSCN on Capacity of Rat Thyroid Gland to Accumulate Astatine211.∗ , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.